We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the latest trading day at $155.82, indicating a +1.99% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.61%. At the same time, the Dow added 0.97%, and the tech-heavy Nasdaq gained 0.33%.
The the stock of hospital operator has fallen by 3.31% in the past month, leading the Medical sector's loss of 3.79% and undershooting the S&P 500's gain of 5.36%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on October 29, 2024. It is anticipated that the company will report an EPS of $2.33, marking a 61.81% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $5.05 billion, down 0.41% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $10.73 per share and revenue of $20.82 billion. These totals would mark changes of +53.72% and +1.32%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.07% upward. Tenet Healthcare presently features a Zacks Rank of #3 (Hold).
Looking at its valuation, Tenet Healthcare is holding a Forward P/E ratio of 14.24. Its industry sports an average Forward P/E of 15.02, so one might conclude that Tenet Healthcare is trading at a discount comparatively.
It is also worth noting that THC currently has a PEG ratio of 0.78. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 1.11 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 13, finds itself in the top 6% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing
Tenet Healthcare (THC - Free Report) closed the latest trading day at $155.82, indicating a +1.99% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.61%. At the same time, the Dow added 0.97%, and the tech-heavy Nasdaq gained 0.33%.
The the stock of hospital operator has fallen by 3.31% in the past month, leading the Medical sector's loss of 3.79% and undershooting the S&P 500's gain of 5.36%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on October 29, 2024. It is anticipated that the company will report an EPS of $2.33, marking a 61.81% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $5.05 billion, down 0.41% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $10.73 per share and revenue of $20.82 billion. These totals would mark changes of +53.72% and +1.32%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.07% upward. Tenet Healthcare presently features a Zacks Rank of #3 (Hold).
Looking at its valuation, Tenet Healthcare is holding a Forward P/E ratio of 14.24. Its industry sports an average Forward P/E of 15.02, so one might conclude that Tenet Healthcare is trading at a discount comparatively.
It is also worth noting that THC currently has a PEG ratio of 0.78. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 1.11 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 13, finds itself in the top 6% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.